Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The distribution of
protein kinase C
(
PKC
) isoforms and phorbol 12-myristate 13-acetate (PMA)-induced activation of
PKC
in human monocytes was investigated. Using Western blot analysis,
PKC
beta was found to be the most abundant isoform in monocytes.
PKC
beta was equally distributed in the cytosol and membrane. PKC-alpha was readily detectable and found predominantly in the cytosol. Little to no
PKC
-epsilon,
gamma, delta
, and zeta were observed. Following the treatment of monocytes with PMA, the physical translocation of
PKC
alpha from the cytosol to the membrane occurred over 60 min. PMA-induced translocation of PKC-beta was difficult to detect by Western blot. Fura-2 analysis demonstrated that PMA-induced
PKC
translocation was not accompanied by a net change in cytosolic calcium levels. Using histone as a substrate for
PKC
activity, an extremely rapid translocation of
PKC
-dependent histone phosphorylation (PKC-DHP) was induced by PMA. Cytosolic
PKC
-DHP activity decreased to undetectable levels within 8 min. In contrast, analysis of
PKC
-dependent endogenous substrate phosphorylation (PKC-DESP) showed a pattern with a time-course similar to that observed with Western blot. Thus, translocation of
PKC
-DESP but not
PKC
-DHP activity correlated with PKC-alpha as determined by Western blot. The data support the concept that
PKC
activity is substrate dependent and suggest that using one assay for the measurement of
PKC
activity may lead to erroneous conclusions.
...
PMID:Protein kinase C activation in human monocytes: regulation of PKC isoforms. 828 12
Defective
protein kinase C
(
PKC
) has been implicated in impaired Na+,K(+)-ATPase activity in the sciatic nerve of streptozotocin-induced diabetic rats. In the present study, alpha, beta I, beta II,
gamma, delta
, and epsilon isoform-specific antibodies were used in parallel to the measurement of compound
PKC
activity for the characterization of
PKC
distribution and isoform expression in sciatic nerves of normal and diabetic rats. To distinguish isoform expression between the axonal and glial compartments,
PKC
isoforms were evaluated in nerves subjected to Wallerian degeneration and in a pure primary Schwann cell culture. alpha, beta I, beta II, delta, and epsilon but no gamma isoforms were detected in sciatic nerve. Similar immunoreactivity was observed in degenerated nerves 3-4 days after transection except for diminished beta I and epsilon species; in Schwann cell cultures, only alpha, beta II, delta, and epsilon were detected. In normal nerves, two-thirds of
PKC
compound activity was found in the cytosol and 50% of total enzyme activity translocated to the Na+,K(+)-ATPase-enriched membrane fraction with phorbol myristate acetate. Similar redistribution patterns were observed for the immunoreactivity of all isoforms with the exception of delta, which did not translocate to the membrane with phorbol myristate acetate. No abnormality in compound
PKC
activity, in the immunoreactive intensity, or in the distribution of
PKC
isoforms could be detected in rat sciatic nerve after 6-12 weeks of diabetes. Thus, defective activation rather than decreased intrinsic
PKC
activity may occur in diabetic neuropathy.
...
PMID:Alpha, beta I, beta II, delta, and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. 829 31
Membrane and cytosol fractions from hepatocytes of both normal and streptozotocin-induced diabetic animals were probed with a panel of polyclonal anti-peptide antisera in order to identify
protein kinase C
(
PKC
) isoforms. Immunoreactive species were noted with antisera specific for alpha (approximately 81 kDa), beta-II (approximately 82 kDA), epsilon (approximately 95 kDa) and epsilon (approximately 79 kDa). In addition, a species migrating with an apparent size of approximately 94 kDa was also detected in cytosol fractions using an antiserum specific for PKC-alpha. Each of these species was specifically displaced when the
PKC
-isoform specific peptide was included in the immunodetection system. No immunoreactive species consistent with the presence of the beta-I,
gamma, delta
and eta isoforms of
protein kinase C
was observed. Induction of diabetes using streptozotocin invoked selective alterations in the expression of
PKC
isoforms which were reversed upon insulin therapy. In the cytosol fraction, marked increases of approximately 3-fold occurred in levels of the beta-II isoform and the approximately 90 kDa (upper) form of PKC-alpha, with no apparent/little change in the levels of the approximately 81 kDa (lower) form of PKC-alpha and those of
PKC
-zeta. Diabetes induction also appeared to have elicited the translocation of PKC-beta-II and the approximately 81 kDa (lower) form of PKC-alpha to the membrane fraction where immunoreactivity for these species was now apparent. The level of
PKC
-epsilon, which was noted only in membrane fractions, was also increased upon induction of diabetes. It is suggested that the selective alterations in the expression of
PKC
isoforms occurring upon streptozotocin-induced diabetes may lead to altered cellular functioning and underly defects in inhibitory G-protein functioning and insulin action which characterise this animal model of diabetes.
...
PMID:Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. 832 59
We investigated whether members of the
protein kinase C
(
PKC
) family of enzymes could play a role in the nuclear events involved in megakaryocytic differentiation.
PKC
activity was analysed using a serine substituted specific peptide, which enabled us to evaluate the whole catalytic activity in the pluripotent haemopoietic HEL cell line treated with 10(-7)M phorbol myristate acetate (PMA) or haemin. In parallel, the subcellular distribution of different
PKC
isoforms (alpha, beta I, beta II,
gamma, delta
, epsilon, theta, eta, zeta) was evaluated by Western blot.
PKC
catalytic activity in the nuclei of HEL cells showed a peak after acute (30 min) treatment with PMA, followed by a significant (P < 0.05) decline after prolonged exposure (72 h) to the same agonist, when most HEL cells had acquired a differentiated megakaryocytic phenotype. Western blot analysis of nuclear lysates consistently showed a significant increase of PKC-alpha, -beta I, -epsilon, theta and -zeta isoforms after 30 min of PMA treatment, followed by a drastic decline of all but
PKC
-zeta isoforms. Moreover,
PKC
-6 delta appeared in HEL nuclei only after 72 h of exposure to PMA. On the other hand, neither the catalytic activity nor the immunoreactivity of the different
PKC
isoforms showed remarkable variations in nuclei of HEL cells induced to differentiate along the erythroid lineage with 10(-7)M haemin. The possible implications of these findings for a better understanding of the molecular events underlying the process of megakaryocytic differentiation are discussed.
...
PMID:PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 861 13
To simplify the detection of the exogenously produced
protein kinase C
(
PKC
) isoforms, we constructed the T7-Tag
PKC
alpha, betaI, betaII,
gamma, delta
and epsilon expression plasmids. T7-Tag sequences (AlaSerMetThrGlyGlyGlnGlnMetGlyArg) were inserted at the 5'-end of the translational initiation site. Transient transfection of T7-Tag
PKC
expression plasmids into CV-1 cells increased the levels of
PKC
protein, and
PKC
activity. T7-Tag-
PKC
epsilon, like native
PKC
epsilon, transactivated the transcription of a NF-kappa B reporter construct. These results indicate that the plasmids encoding T7-Tag
PKC
are functional and may be useful to define the role
PKC
isoforms play in cell proliferation, differentiation and tumor promotion.
...
PMID:Functional expression and characterization of the mouse epitope tag-protein kinase C isoforms, alpha, beta I, beta II, gamma, delta and epsilon. 864 65
A correlation of the levels of epidermal
protein kinase C
(
PKC
) isozymes, steady state levels of ornithine decarboxylase (ODC) mRNA, and ODC antizyme with the induction of ornithine decarboxylase (ODC) activity by a second repeat 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment to mouse skin was determined. A single application of TPA to female CD-1 mouse skin leads to a dramatic induction of ODC activity (approximately 3 nmol CO2/60 min/mg protein) which peaks at about 5 h after treatment. However, a superinduction of ODC activity (approximately 13 CO2/60 min/mg protein) is observed upon the second TPA application at 48 or 72 h after the first TPA treatment. Prior application of a tumor initiating dose of 7,12-dimethylbenz[a]anthracine to mouse skin did not influence the degree of induction of ODC by a repeat TPA treatment. Western Blot analyses using antibodies specific to
PKC
alpha, beta,
gamma, delta
and epsilon indicate detectable levels of
PKC
alpha, beta, delta and epsilon in mouse epidermal extracts. A time course of the effects of a single topical application of 20 nmol of TPA to the mouse skin indicate that none of
PKC
isozymes (alpha, beta,
gamma, delta
and epsilon) were completely downregulated at times (72 h) when ODC was overinduced by TPA. TPA-induced steady state levels of ODC mRNA did not correlate with the degree of superinduction of ODC activity by TPA. The second TPA treatment, 72 h after the first TPA treatment, which leads to superinduction of ODC activity did not decrease the levels of the ODC-antizyme. The results indicate that superinduction of mouse epidermal ODC activity is regulated in part post-transcriptionally and may not be the result of either a loss of
PKC
isoform(s) or a decrease in the levels of ODC antizyme.
...
PMID:Superinduction of mouse epidermal ornithine decarboxylase activity by repeated 12-o-tetradecanoylphorbol-13-acetate treatments. 870 Jan 59
To investigate the regulation of promoters containing classical phorbol ester response sequences (PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs) by
protein kinase C
(
PKC
) isozymes, co-transfections were performed in human dermal fibroblasts with a plasmid containing either the human collagenase promoter or the porcine urokinase plasminogen activator (uPA) promoter linked to the chloramphenicol acetyltransferase gene and a plasmid expressing an individual
PKC
isozyme. Using this experimental design, seven
PKC
isozymes were analyzed for their ability to trans-activate the collagenase and uPA promoters. Our results demonstrate that only
PKC
delta, epsilon, and eta trans-activated the collagenase promoter and that binding of Ap-1 family members to the collagenase 12-O-tetradecanoylphorbol-13-acetate response element (TRE) was not responsible for the isozyme-specific trans-activation. In contrast, the uPA promoter was stimulated by all of the
PKC
isozymes examined (
PKC
alpha, betaII,
gamma, delta
, epsilon, zeta, and eta). These results indicate that
PKC
isozymes differentially regulate promoters containing PEA-3/TRE motifs and suggest that individual isozymes play unique roles within the cell.
...
PMID:Protein kinase C isozymes differentially regulate promoters containing PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs. 870 56
1. Enhanced synthesis of prostacyclin (PGI2) and inositol polyphosphates in bovine aortic endothelial cells in response to ATP and ADP is mediated by co-existing P2Y- and P2U-purinoceptors. Here we examine the regulation of these responses by isoforms of
protein kinase C
(
PKC
). 2. Immunoblots with antisera specific for 8 different
PKC
isoforms revealed the presence of alpha, epsilon and zeta, while no immunoreactivity was found for beta,
gamma, delta
, eta and theta isoforms. PKC-alpha was largely cytosolic in unstimulated cells and almost all translocated to the membrane (Triton X-100 soluble) after a 1 min treatment with the
PKC
activating phorbol myristate acetate (PMA);
PKC
-epsilon was always in a Triton X-100 insoluble membrane fraction, while
PKC
-zeta was found in both soluble and membrane bound (Triton X-100 soluble) forms in the unstimulated cells and was unaffected by PMA. 3. Treatment with PMA for 6 h led to a 90% downregulation of PKC-alpha, while the immunoreactivity to the epsilon and zeta isoforms remained largely unchanged. 4. After either 10 min or 6 h exposure to PMA the PGI2 response to activation of both receptors was enhanced, while the inositol 1,4,5-trisphosphate response to P2Y-purinoceptor activation was substantially attenuated and the P2U-purinoceptor response was unchanged. Thus the PGI2 response to PMA under conditions when 90% of the PKC-alpha was lost resembles that seen on acute stimulation of
PKC
by PMA, and the PGI2 response does not correlate with phospholipase C response. 5. Inhibition of
PKC
with the isoform non-selective inhibitors, Ro 31-8220 and Go 6850 abolished the PGI2 response to both P2U- and P2Y-purinoceptor stimulation. However, Go 6976, which preferentially inhibits Ca2+ sensitive isoforms (such as PKC-alpha) and not Ca2+ insensitive isoforms (such as
PKC
-epsilon), had no effect on the PGI2 response. 6. The results show that there is a requirement for
PKC
in the stimulation of PGI2 production by endothelial P2Y- and P2U-purinoceptors. Both downregulation and inhibition studies show that PKC-alpha is not responsible for the regulation of the response to P2-purinergic stimulation, and imply that the response is mediated by
PKC
-epsilon (
PKC
-zeta is unresponsive to PMA), or an as yet uncharacterized
PKC
isoform.
...
PMID:Protein kinase C isoforms in bovine aortic endothelial cells: role in regulation of P2Y- and P2U-purinoceptor-stimulated prostacyclin release. 873 84
We have investigated the role of
protein kinase C
(
PKC
) isoenzymes in the differential growth regulation of human pancreatic carcinoma cell lines by all-trans retinoic acid (RA). RA treatment results in dose-dependent stimulation of anchorage-independent growth in AsPc1 cells and growth inhibition in Capan 2 cells. Both cell lines express an identical pattern of nuclear RA and retinoid X receptors as determined by RT-PCR. Western blotting using monospecific antibodies revealed that both cell lines express
PKC
isoenzymes alpha and zeta, whereas beta,
gamma, delta
, and epsilon were not detected. Incubation with RA in the growth-stimulated AsPc1 cell line resulted in induction of
PKC
alpha expression, whereas
PKC
alpha expression was decreased by RA in the growth-inhibited Capan 2 cell line. In contrast, PKC zeta expression was not affected by RA in either cell line. Incubation of AsPc1 cells with the phorbol ester 12-O-tetradecanoyl phorbol 13-acetate resulted in a time- and dose-dependent selective down-regulation of
PKC
alpha but not zeta. The dose-dependent decrease of intracellular
PKC
alpha concentration correlated well with the anchorage-independent growth rate of AsPc1 cells. Furthermore, selective down-regulation of
PKC
alpha blocks subsequent growth stimulation by RA in AsPc1 cells. When
PKC
alpha concentration was decreased by stably transfecting AsPc1 cells with a
PKC
alpha complementary DNA antisense construct, RA-stimulated growth could also be partially blocked. These data, therefore, suggest that differential regulation of
PKC
alpha expression plays a central role in determining the bidirectional effects of RA on growth in pancreatic carcinoma cells.
...
PMID:Differential growth regulation by all-trans retinoic acid is determined by protein kinase C alpha in human pancreatic carcinoma cells. 875 60
Lymphocyte migration into inflammatory sites involves a change from a spherical, non-motile phenotype to an irregular, constantly shape-changing, motile phenotype. We have previously shown that lymphocytes are maintained in the non-motile state by the constitutive activity of
protein kinase C
(
PKC
). In this paper we have attempted to identify the
PKC
isotype which regulates these morphological changes by three different approaches. (a) Motile and non-motile T-cell lines were compared for expression of the alpha, beta I, beta II,
gamma, delta
, epsilon, eta, zeta and theta isotypes by Western blotting. There was no obvious correlation of isotype expression with motility. (b) Two different
PKC
inhibitors, one specific for classical isotypes, Go6976 and the other GF109203X, which inhibits both classical and non-classical isotypes were compared for induction of motility in non-motile lymphocytes. Only GF109203X induced motility implying that a non-classical isotype is involved. (c) Non-motile lymphocytes were chronically treated with the
PKC
activator bryostatin and the time courses of induction of motility and downregulation of
PKC
isotypes were compared. Induction of motility correlated better with downregulation of epsilon, eta and theta than with alpha or beta. It is concluded that the data fit best with the involvement of a non-classical
PKC
isotype in regulating lymphocyte motility although no association with a particular isotype was found.
...
PMID:Protein kinase C isotype expression and regulation of lymphoid cell motility. 877 30
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>